1887
Rapid communication Open Access
Like 2

Abstract

Two months after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the possibility of established and widespread community transmission in the European Union and European Economic Area (EU/EEA) is becoming more likely. We provide scenarios for use in preparedness for a possible widespread epidemic. The EU/EEA is moving towards the ‘limited sustained transmission’ phase. We propose actions to prepare for potential mitigation phases and coordinate efforts to protect the health of citizens.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.9.2000202
2020-03-05
2024-03-29
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.9.2000202
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/9/eurosurv-25-9-2.html?itemId=/content/10.2807/1560-7917.ES.2020.25.9.2000202&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). COVID-19 - Situation update – worldwide. Stockholm: ECDC; 1 Mar 2020. Available from: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
  2. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. China CDC Weekly. 2020;2(8):113-22. Available from: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51?from=timeline&isappinstalled=0
  3. European Centre for Disease Prevention and Control (ECDC). Public health management of persons having had contact with cases of novel coronavirus in the European Union, 25 February 2020. Stockholm: ECDC, 25 Feb 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-public-health-management-contact-novel-coronavirus-cases-EU.pdf
  4. European Centre for Disease Prevention and Control (ECDC). Communicable Disease Threats Report - Week 9, 23-29 February 2020. Stockholm: ECDC, 28 Feb 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Communicable%20disease%20threats%20report%2C%2023-29%20February%202020%2C%20week%209.pdf
  5. European Commission. Commission decision 1082/2013/EU of the European Parliament and of the Council of 22 October 2013 on serious cross-border threats to health and repealing Decision No 2119/98/EC. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. L293/1. 5 Nov 2013. Available from: http://ec.europa.eu/health/preparedness_response/docs/decision_serious_crossborder_threats_22102013_en.pdf
  6. Reusken CBEM, Broberg EK, Haagmans B, Meijer A, Corman VM, Papa A, et al. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020. Euro Surveill. 2020;25(6):2000082.  https://doi.org/10.2807/1560-7917.ES.2020.25.6.2000082  PMID: 32046815 
  7. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689-97.  https://doi.org/10.1016/S0140-6736(20)30260-9  PMID: 32014114 
  8. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;NEJMc2001468.  https://doi.org/10.1056/NEJMc2001468  PMID: 32003551 
  9. De Salazar PM, Niehus R, Taylor A, Buckee CO, Lipsitch M. Using predicted imports of 2019-nCoV cases to determine locations that may not be identifying all imported cases. medRxiv. 2020:2020.02.04.20020495. (Preprint). Available from: https://www.medrxiv.org/content/10.1101/2020.02.04.20020495v2
/content/10.2807/1560-7917.ES.2020.25.9.2000202
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error